Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02075190 · ClinicalTrials.gov registry record · NA
Trial of a Nationwide Cognitive-Affective Remediation Training Intervention in Depression
A NA study, sponsored by Stanford University.
- Terminated
- Registry status
- NA
- Development phase
- 89
- Enrollment target
NCT02075190: Clinical Trial NA study, sponsored by Stanford University.
NCT02075190 is a NA study that was terminated before completion, run by Stanford University. The registered enrollment target is 89 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02075190, a NA study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- NA
- Development phase
- 89 participants
- Enrollment target
Study Summary
The objective is to examine the efficacy of computerized interventions for increasing well-being and cognitive functioning. The study will seek to validate emerging online delivery methods of psychiatric assessment and treatment. This will allow us to test the efficacy of this intervention in a larger and more geographically broad sample than is possible through traditional recruitment and treatment, and to do so in a highly cost-effective manner.
Primary Outcome
Behavioral measure of executive functions
Interventions
- OTHER Therapeutic Computerized intervention
- OTHER Nontherapeutic computerized intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2014-02 |
| Est. Completion | 2015-08 |
| Phase | NA |
Why NCT02075190 stopped before completion
NCT02075190 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 89 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Therapeutic Computerized intervention is the first listed.
NCT02075190 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02075190 about?
NCT02075190 is a clinical study titled "Trial of a Nationwide Cognitive-Affective Remediation Training Intervention in Depression". The objective is to examine the efficacy of computerized interventions for increasing well-being and cognitive functioning. The study will seek to validate emerging online delivery methods of psychiatric assessment and treatment. This will allow us to test the efficacy of this intervention in a larg...
What is the current status of trial NCT02075190?
This trial is currently terminated. It is a NA study. The enrollment target is 89 participants. The study started on 2014-02. Estimated completion is 2015-08.
What interventions are being tested in trial NCT02075190?
The interventions under investigation include: Therapeutic Computerized intervention (OTHER), Nontherapeutic computerized intervention (OTHER).
Who is sponsoring clinical trial NCT02075190?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02075190's enrollment target sits among peer trials
89 972nd of 2000 higher than 1,029 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03682289 · 89 participants · Phase 2
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
- NCT04787939 · 89 participants · NA
Early Feeding After Oral Cavity Reconstruction
- NCT05480449 · 89 participants · Phase 1
Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)
- NCT05604131 · 89 participants · Phase 2
Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia